文献速递产科母胎医学

妊娠期血管性血友病、血友病及其他遗传性出血性疾病

Von Willebrand Disease, Hemophilia, and Other Inherited Bleeding Disorders in Pregnancy.
PubMed 文献 · Obstet Gynecol · 2023-02-02

综述汇总妊娠期遗传性出血性疾病的母胎管理要点:最常见为血管性血友病(VWD);母体管理包括妊娠晚期检测凝血因子水平、因子水平低于阈值时转诊至有止血专业知识的中心并使用止血药物;胎儿管理包括孕前咨询、血友病胚胎植入前遗传学检测、可能受累男婴考虑剖宫产及在有新生儿重症监护和儿科止血专业知识的机构分娩。

要点

  • 妊娠晚期应检测凝血因子水平,因子水平低于最低阈值时应在具备止血专业知识的中心分娩。
  • 母体可使用凝血因子浓缩物、去氨加压素或氨甲环酸等止血药物。
  • 胎儿管理包括孕前咨询、血友病胚胎植入前遗传学检测,可能受累男婴可考虑剖宫产。

核心结论

  • 遗传性出血性疾病对母体和胎儿均有影响,妊娠期需进行母胎相关管理。

研究设计与样本

  • 综述,汇总妊娠期遗传性出血性疾病的母胎管理一般性指导。

主要发现

  • 已诊断的出血性疾病中女性最常见的是血管性血友病(VWD),轻度血小板缺陷可能实际更常见。
  • 血友病携带者其他出血性疾病中较少见,但可能分娩严重受累的男婴。

关键数值与推荐

  • 妊娠晚期检测凝血因子水平。
  • 若因子水平未达最低阈值(如血管性血友病因子、因子VIII或因子IX低于0.50国际单位/1毫升[50%]),应在具备止血专业知识的中心分娩。
  • 可使用凝血因子浓缩物、去氨加压素或氨甲环酸等止血药物。
  • 胎儿管理包括孕前咨询、血友病胚胎植入前遗传学检测的选项,以及可能受累的男性血友病新生儿考虑剖宫产以降低新生儿颅内出血风险。
  • 可能受累新生儿应在具备新生儿重症监护和儿科止血专业知识的机构分娩。

临床怎么用

  • 妊娠晚期检测凝血因子水平,因子水平低于阈值时转诊至有止血专业知识的中心并使用止血药物。
  • 可能受累新生儿应在具备新生儿重症监护和儿科止血专业知识的机构分娩。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inherited bleeding disorders, which comprise von Willebrand disease (VWD), hemophilia, other congenital clotting factor deficiencies, inherited platelet disorders, defects of fibrinolysis, and connective tissue disorders, have both maternal and fetal implications. Although mild platelet defects may actually be more prevalent, the most common diagnosed bleeding disorder among women is VWD. Other bleeding disorders, including hemophilia carriership, are much less common, but hemophilia carriers are unique in that they are at risk of giving birth to a severely affected male neonate. General guidance for maternal management of inherited bleeding disorders includes obtaining clotting factor levels in the third trimester, planning for delivery at a center with hemostasis expertise if factor levels do not meet the minimum threshold (eg, less than 0.50 international units/1 mL [50%] for von Willebrand factor, factor VIII, or factor IX), and using hemostatic agents such as factor concentrates, desmopressin, or tranexamic acid. General guidance for fetal management includes prepregnancy counseling, the option of preimplantation genetic testing for hemophilia, and consideration of delivery of potentially affected male neonates with hemophilia by cesarean delivery to reduce the risk of neonatal intracranial hemorrhage. In addition, delivery of possibly affected neonates should occur in a facility where there is newborn intensive care and pediatric hemostasis expertise. For patients with other inherited bleeding disorders, unless a severely affected neonate is anticipated, mode of delivery should be dictated by obstetric indications. Nonetheless, invasive procedures such as fetal scalp clip or operative vaginal delivery should be avoided, if possible, in any fetus potentially affected with a bleeding disorder.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pacheco LD, Saade GR, James AH, et al. Von Willebrand Disease, Hemophilia, and Other Inherited Bleeding Disorders in Pregnancy. Obstet Gynecol. 2023. PMID: 36800851. doi:10.1097/AOG.0000000000005083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。